Evoke Pharma Inc. (NASDAQ: EVOK) Launches Physician and Patient Experience Program for GIMOTI
Evoke Pharma Inc. (NASDAQ: EVOK) dropped 3.17% after the company announced the commencement of more marketing initiatives focusing on introducing physician and patient experience programs for GIMOTI, its nasal spray of relief of acute and recurrent diabetic gastroparesis (DGP) symptoms. Evoke launches GIMOTI experience program The program will offer GIMOTI samples mainly to advance practice practitioners and targeted gastroenterologists. Most importantly, the program will expand GIMOTI awareness and trials for…